These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27496822)

  • 1. Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men.
    Asferg CL; Andersen UB; Linneberg A; Hedley PL; Christiansen M; Goetze JP; Jeppesen JL
    Heart; 2017 Jan; 103(2):154-158. PubMed ID: 27496822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obese Hypertensive Men Have Lower Circulating Proatrial Natriuretic Peptide Concentrations Despite Greater Left Atrial Size.
    Asferg CL; Andersen UB; Linneberg A; Goetze JP; Jeppesen JL
    Am J Hypertens; 2018 May; 31(6):645-650. PubMed ID: 29471357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure.
    Asferg CL; Andersen UB; Linneberg A; Hedley PL; Christiansen M; Goetze JP; Jeppesen JL
    Peptides; 2020 Dec; 134():170390. PubMed ID: 32882353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men.
    Asferg CL; Nielsen SJ; Andersen UB; Linneberg A; Møller DV; Hedley PL; Christiansen M; Goetze JP; Esler M; Jeppesen JL
    Hypertension; 2013 Jul; 62(1):147-53. PubMed ID: 23670298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum proatrial natriuretic peptide concentrations during oral glucose-induced acute hyperinsulinemia in lean and obese men.
    Asferg CL; Nielsen SJ; Andersen UB; Linneberg A; Goetze JP; Jeppesen JL
    Peptides; 2019 Jan; 111():98-102. PubMed ID: 29524563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic rather than body composition measurements are associated with lower serum natriuretic peptide concentrations in normal weight and obese men.
    Asferg CL; Nielsen SJ; Andersen UB; Linneberg A; Møller DV; Hedley PL; Christiansen M; Gøtze JP; Jeppesen JL
    Am J Hypertens; 2014 Apr; 27(4):620-7. PubMed ID: 24025723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S; Sciarretta S; Ciavarella GM; Venturelli V; De Paolis P; Tocci G; De Biase L; Ferrucci A; Volpe M
    J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations among obesity, blood pressure, and left ventricular mass.
    Maggio AB; Aggoun Y; Marchand LM; Martin XE; Herrmann F; Beghetti M; Farpour-Lambert NJ
    J Pediatr; 2008 Apr; 152(4):489-93. PubMed ID: 18346502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population.
    Goharian TS; Goetze JP; Faber J; Andersen LB; Grøntved A; Jeppesen JL
    Am J Hypertens; 2017 Jun; 30(6):561-568. PubMed ID: 28338810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals.
    Parcha V; Patel N; Gutierrez OM; Li P; Gamble KL; Musunuru K; Margulies KB; Cappola TP; Wang TJ; Arora G; Arora P
    J Am Coll Cardiol; 2021 May; 77(18):2291-2303. PubMed ID: 33958126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of home blood pressure with target-organ damage in children and adolescents.
    Stergiou GS; Giovas PP; Kollias A; Rarra VC; Papagiannis J; Georgakopoulos D; Vazeou A
    Hypertens Res; 2011 May; 34(5):640-4. PubMed ID: 21326307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension.
    Partanen N; Husso M; Vuolteenaho O; Sipola P; Ruskoaho H; Peuhkurinen K; Magga J
    J Hum Hypertens; 2011 Dec; 25(12):746-51. PubMed ID: 21248782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.
    Khaleghi M; Al-Omari MA; Kondragunta V; Morgenthaler NG; Struck J; Bergmann A; Mosley TH; Kullo IJ
    Am J Cardiol; 2009 May; 103(9):1255-60. PubMed ID: 19406268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma.
    Melander O; von Wowern F; Frandsen E; Burri P; Willsteen G; Aurell M; Hulthén UL
    J Hypertens; 2007 Mar; 25(3):619-27. PubMed ID: 17278979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure and left ventricular mass in older age.
    Wendelin-Saarenhovi M; Isoaho RE; Hartiala JJ; Helenius HY; Kivelä SL; Löppönen MK; Puolijoki H; Hietanen EK
    Scand J Clin Lab Invest; 2002; 62(8):569-77. PubMed ID: 12564615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the time rate of blood pressure variation on left ventricular mass.
    Zakopoulos NA; Tsivgoulis G; Barlas G; Spengos K; Manios E; Ikonomidis I; Toumanidis S; Dolianitis K; Vemmos K; Vassilopoulos D; Moulopoulos SD
    J Hypertens; 2006 Oct; 24(10):2071-7. PubMed ID: 16957568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
    Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
    Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?
    Rasmussen JJ; Schou M; Madsen PL; Selmer C; Johansen ML; Hovind P; Ulriksen PS; Faber J; Gustafsson F; Kistorp C
    J Hypertens; 2018 Feb; 36(2):277-285. PubMed ID: 28863033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.